Artthur Pappas, CEO & Managing General Partner at Pappas Capital, Durham, NC — verified investor profile. See sector focus and contact routes.
Art Pappas, CEO of Pappas Capital, invests primarily in life sciences—including biotechnology, biopharmaceuticals, drug delivery, and medical devices—targeting companies from seed stage through later-stage mezzanine, with a focus on Phase 1 or Phase 2 development. The firm has invested in over 100 portfolio companies, with notable exits including 14 IPOs (e.g., Reneo Pharmaceuticals, BioAtla) and 30 acquisitions such as VelosBio and NuVasive. Pappas Capital’s distinctive thesis emphasizes translating scientific discoveries into viable medical solutions by partnering with corporate LPs and co-investors, particularly in research-rich regions often overlooked by general venture funding.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Durham.
Investors like Artthur Pappas · Full investor directory · Investor access · Company funding database